Trademark: 86487600
Word
INTEGRALABS
Status Date
Friday, April 5, 2024
Registration Number
5293679
Registration Date
Tuesday, September 26, 2017
Filing Date
Monday, December 22, 2014
Published for Opposition
Tuesday, December 29, 2015
Cancellation Date
Friday, April 5, 2024
44 Medical laboratory services, namely, medication monitoring and drug detection services to evaluate patient treatment plans; drug use testing services, including testing for drug use screening, medication abuse and compliance with physician prescribing instructions; and DNA and genetic testing services for medical purposes, all of the foregoing excluding all activities related to the use of radioisotopes for nuclear medicine imaging and treatment
42 Clinical laboratory testing services marketed and sold to physicians and other medical providers, specifically operation of molecular and pathology laboratories that provide third-party testing and/or collection and testing of patient blood, urine, oral fluids and/or other specimens, all of the foregoing excluding medical laboratory conception, design, installation, integration and validation services as well as excluding all activities related to the use of radio-isotopes for nuclear medicine imaging and treatment
The mark consists of the word "IntegraLabs" with the first letter, "I", and the eighth letter, "L", capitalized. The letter "L" extends in a straight horizontal line under the subsequent letters "abs". The literal element of the mark is preceded by a six (6) hexagon design in the upper left hand corner to the left and above the letter "I", with four (4) hexagons of the design increasing in size in a clockwise direction beginning on the left side of the "I" and continuing to the right, followed by two (2) hexagons decreasing in size in a counter-clockwise direction ending above the "n" in "IntegraLabs".
In the Statement, line 20, after PURPOSES, ", all of the foregoing excluding all activities related to the use of radioisotopes for nuclear medicine imaging and treatment" should be inserted.
INTEGRA LABS; INTEGRA LABORATORIES
Color is not claimed as a feature of the mark.
Apr 1, 2015
Assigned To Examiner
Dec 25, 2014
New Application Entered
Dec 29, 2014
New Application Office Supplied Data Entered
Dec 30, 2014
Notice Of Design Search Code E-Mailed
Apr 1, 2015
Non-Final Action Written
Apr 1, 2015
Notification Of Non-Final Action E-Mailed
Apr 1, 2015
Non-Final Action E-Mailed
Sep 25, 2015
Teas Response To Office Action Received
Sep 25, 2015
Correspondence Received In Law Office
Sep 26, 2015
Teas/Email Correspondence Entered
Oct 20, 2015
Examiners Amendment E-Mailed
Oct 20, 2015
Examiners Amendment -Written
Oct 20, 2015
Examiner's Amendment Entered
Oct 20, 2015
Notification Of Examiners Amendment E-Mailed
Oct 20, 2015
Approved For Pub - Principal Register
Dec 9, 2015
Notification Of Notice Of Publication E-Mailed
Apr 27, 2016
Opposition Instituted No. 999999
Aug 21, 2017
Opposition Dismissed No. 999999
Sep 26, 2017
Registered-Principal Register
May 4, 2018
Correction Under Section 7 - Processed
Dec 29, 2015
Published For Opposition
Dec 29, 2015
Official Gazette Publication Confirmation E-Mailed
Jan 25, 2016
Extension Of Time To Oppose Received
Aug 21, 2017
Opposition Terminated No. 999999
Aug 21, 2017
Ttab Release Case To Trademarks
Sep 26, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Apr 5, 2024
Cancelled Sec. 8 (6-Yr)
Trademark Alertz updated from USPTO on 2030-01-24
